Support: 888-992-3836
|
NewsWire
|
Home
|
Login / Register
Boards
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
Hot!
Breakout Boards
Follow Feed
iHub My Stocks Activity
Ticker Buzz Cloud
Most Read
Most Posted
Most Followed Members
Recent News
News By Market
Active Boards
Site Stats
New Boards
Cannabis Stocks
Top PlusOneCoin Posters
Tools
Data Tools >
Charts
Trader Alerts
Trades
Portfolio
Top Lists
Price & News Alerts
Commodities
NewsWire
More Tools >
Newsletters
InvestorsHub Daily
My Image Gallery
Advanced Search
All News
Stock Screener
News Filter
Live Charts
Live News
Live Desktop
Forex Prices
Commodities
Educational Channel
Follow Feed
News Scanner
Crypto
Top Cryptocurrencies
PLUS1 Info & Faucet
Top Tokens
New Cryptocurrencies
Crypto Converter
Streamer
Level 2
Home
>
Boards
>
US Listed
>
Biotechs
>
Vascular Biogenics Ltd. (VBLT)
Add VBLT Price Alert
Hide Sticky
Hide Intro
Moderator:
Search This Board:
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003+
Last Post:
12/20/2021 8:20:40 AM
-
Followers:
47
- Board type:
Free
- Posts Today:
0
Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels.
http://www.vblrx.com
VBLT
Current Price
Volume:
Bid
Ask
Day's Range
VBLT Detailed Quote
1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y
VBLT News: H.C. Wainwright Sticks to Their Buy Rating for Vascular Biogenics (VBLT)
02:17 AM
VBLT News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
05/17/2022 03:01:39 AM
VBLT News: Analysts’ Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Vascular Biogenics (VBLT)
04/27/2022 02:15:21 AM
VBLT News: JonesTrading Sticks to Its Buy Rating for Vascular Biogenics (VBLT)
04/11/2022 12:15:20 PM
VBLT News: Analysts Offer Insights on Healthcare Companies: Vascular Biogenics (VBLT) and Mustang Bio (MBIO)
03/24/2022 02:15:18 AM
News Alert:
H.C. Wainwright Sticks to Their Buy Rating for Vascular Biogenics (VBLT)
05/18/2022 02:17:21 AM
Post New Msg
Follow Board
My Stocks (23)
Hide Intro
View Posters
VBLT Poststream
Bans (0)
Hide Quote
Filter Disabled
Post
Subject
#2039
VBL Therapeutics Selected for €17.5 Million of Funding
midastouch017
12/20/21 08:20:40 AM
#2038
Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on
midastouch017
11/15/21 02:16:48 PM
#2037
VBL Therapeutics Reports Third Quarter 2021 Financial Results
midastouch017
11/15/21 08:21:01 AM
#2036
VBL Therapeutics to Report Third Quarter Financial Results
midastouch017
11/08/21 08:32:39 AM
#2035
Form 6-K
midastouch017
10/21/21 08:37:58 AM
#2034
VBL Therapeutics Announces Appointment of Sam Backenroth as
midastouch017
10/05/21 08:17:36 AM
#2033
VBL Therapeutics on go with Phase 3 VB-111
midastouch017
09/17/21 08:37:00 AM
#2032
VBL Therapeutics Announces Independent Data Safety Monitoring Committee
midastouch017
09/17/21 08:25:49 AM
#2031
VBL Therapeutics to Present at Upcoming Conferences
midastouch017
09/10/21 09:16:14 AM
#2030
Vascular Biogenics Trial Nears Full Enrollment, Price Could Jump
midastouch017
09/03/21 08:12:38 AM
#2029
2.5300+0.1900 (+8.12%)
midastouch017
09/02/21 12:20:18 PM
#2028
VBL Therapeutics jumps 12% after resuming U.S. enrollment
midastouch017
08/30/21 08:08:33 AM
#2027
VBL Therapeutics Resumes U.S. Enrollment in OVAL Phase
midastouch017
08/30/21 07:59:24 AM
#2026
I gathered all the data I have and
Oren1976
08/28/21 11:27:34 AM
#2025
Vascular Biogenics Ltd (VBLT) CEO Dror Harats on
midastouch017
08/16/21 11:12:35 AM
#2024
VBL Therapeutics Reports Second Quarter 2021 Financial Results
midastouch017
08/16/21 07:30:38 AM
#2023
VBL Therapeutics Q2 2021 Earnings Preview
midastouch017
08/15/21 09:01:29 AM
#2022
Vascular Biogenics Ltd. (NASDAQ:VBLT) Expected to Announce Quarterly
midastouch017
08/15/21 08:26:22 AM
#2021
Vascular Biogenics Ltd. (NASDAQ: VBLT)
midastouch017
08/06/21 12:35:51 PM
#2020
VBL Therapeutics to Report Second Quarter Financial Results
midastouch017
08/05/21 08:16:39 AM
#2019
VBL Therapeutics Provides Update on OVAL, a Phase
midastouch017
06/15/21 08:31:12 AM
#2018
Vascular Biogenics trades lower after an update on
midastouch017
06/15/21 08:29:21 AM
#2017
VBL Therapeutics: Feeling Bullish After VB-111 Clinical Trial Amendment
midastouch017
06/11/21 04:49:45 AM
#2016
VBL Therapeutics Announces Addition of Progression Free Survival
midastouch017
06/03/21 08:18:59 AM
#2015
Looks like same numbers as last review, good
MF82
03/04/21 08:21:45 AM
#2014
I agree on the data, but the change
MF82
02/25/21 06:26:04 PM
#2013
Yes but here we have data that vb111
Oren1976
02/25/21 05:01:08 PM
#2012
Oren, doesn’t this Dsmc PR sound just like
MF82
02/25/21 08:19:54 AM
#2011
Biggest volume I’ve seen on this stock and
MF82
02/23/21 01:23:42 PM
#2010
$VBLT the word unanimously is missing in this
Oren1976
02/23/21 12:35:28 AM
#2009
In recent presentation at Wainwright convention CEO said
Oren1976
11/16/20 09:27:26 AM
#2008
I too have been following this company for
Ihub58
10/11/20 07:02:10 PM
#2007
1 more year to buy the stock at
Oren1976
10/11/20 11:42:16 AM
#2006
Breaking News: $VBLT
VBL Therapeutics to Present at
whytestocks
09/29/20 10:00:28 PM
#2005
* * $VBLT Video Chart 09-11-2020 * *
ClayTrader
09/11/20 04:57:19 PM
#2004
No pump here The news this morning from
Ihub58
09/11/20 01:14:55 PM
#2003
$VBLT VBL Therapeutics Presents MOSPD2 Bi-Specific Antibody Activity
Golden_Cross
06/22/20 08:04:25 AM
#2002
It's old news just presentation . The good
Oren1976
06/01/20 11:41:23 PM
#2001
Great news released this morning We are going
Ihub58
06/01/20 07:13:10 AM
#2000
They mentioned 69% responders in febrile patients so
Oren1976
05/16/20 03:37:20 AM
#1999
The CEO already spoke today about next interim
Oren1976
05/14/20 09:41:41 AM
#1998
Company is blinded. The 9 responders might belong
mantoo123
03/30/20 06:00:13 PM
#1997
They hid 9 complete responders. It was revealed
Oren1976
03/28/20 11:30:31 PM
#1996
So obvious they are letting a large fund
cjstocksup
03/27/20 11:08:45 AM
#1995
Nice CJ
Daytrader0001
03/27/20 08:51:04 AM
#1994
VBLT 9 patients had complete response . Its
cjstocksup
03/27/20 05:33:55 AM
#1993
Moving up fast
WALL$TREET
03/26/20 09:24:53 AM
#1992
VBLT News - VBL Therapeutics Announces Positive Outcome
cjstocksup
03/26/20 08:21:30 AM
#1991
Why the 12% drop?
mantoo123
12/23/19 10:47:12 AM
#1990
. "So I can tell you that the
Oren1976
11/16/19 11:49:02 PM
Post
Subject
Post New Msg
Follow Board
My Stocks (23)
Hide Intro
View Posters
VBLT Poststream
Bans (0)
Hide Quote
Filter Disabled
Balance Available:
0
Get FREE PlusOneCoins!
© 2022 InvestorsHub.com, Inc.
Consent Preferences